| IUPAC name
| Other names
|3D model (Jmol)|| Interactive image|
|Molar mass||266.39 g·mol−1|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|(what is ?)|
Dibenzylpiperazine (DBZP) is a piperazine derivative often found as an impurity in the recreational stimulant drug benzylpiperazine (BZP). Presence of DBZP is a marker for low quality or badly made BZP. It can be made as a reaction byproduct during BZP synthesis, either because the reaction has been run at too high a temperature, or because an excess of benzyl chloride has been used.
Pharmacology and effects
It is not known to have any stimulant effects in its own right, although this has not been tested.
The toxicity of DBZP is unknown.
DBZP is not scheduled as a controlled substance at the federal level in the United States. It is possible that it could be considered an analog BZP, in which case, sales or possession intended for human consumption could be prosecuted under the Federal Analog Act.
- 1-Methyl-4-benzylpiperazine (MBZP)
- 3-Chlorophenylpiperazine (mCPP)
- 3-Trifluoromethylphenylpiperazine (TFMPP)
- 3,4-Methylenedioxy-1-benzylpiperazine (MDBZP)
- 4-Bromo-2,5-dimethoxy-1-benzylpiperazine (2C-B-BZP)
- 4-Fluorophenylpiperazine (pFPP)
- 4-Methoxyphenylpiperazine (MeOPP)
- "关于印发《非药用类麻醉药品和精神药品列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
- 21 CFR — Schedules of Controlled Substances §1308.11 Schedule I.
- "Florida Statutes - Chapter 893 - Drug Abuse Prevention and Control".